Drugs / Tumor-draining lymph node-derived lymphocyte
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05981014 | Aug 2023 → Dec 2030 expected | breast neoplasm | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tumor-draining lymph node-derived lymphocyte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05981014 ↗ |